GNMK
GenMark Diagnostics, Inc
GNMK
GNMK
Delisted
GNMK was delisted on the 21st of April, 2021.
89 hedge funds and large institutions have $392M invested in GenMark Diagnostics, Inc in 2015 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 39 increasing their positions, 21 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
89
Holders Change
+9
Holders Change %
+11.25%
% of All Funds
2.4%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
14
Increased
39
Reduced
21
Closed
5
Calls
$64K
Puts
$46K
Net Calls
+$18K
Net Calls Change
-$9K
Top Buyers
| 1 |
GTC
Ghost Tree Capital
New York
|
+$6.8M |
| 2 |
CCM
Cadian Capital Management
New York
|
+$4.38M |
| 3 |
FAM
Fred Alger Management
New York
|
+$3.36M |
| 4 |
JGC
J. Goldman & Co
New York
|
+$2.73M |
| 5 |
TCM
Tekla Capital Management
Boston,
Massachusetts
|
+$1.95M |
Top Sellers
| 1 |
Jennison Associates
New York
|
-$6.07M |
| 2 |
Parnassus Investments
San Francisco,
California
|
-$5.48M |
| 3 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
-$4.21M |
| 4 |
Millennium Management
New York
|
-$1.79M |
| 5 |
PI
Putnam Investments
Boston,
Massachusetts
|
-$1.69M |
